The use of adrenalectomy as a treatment for congenital adrenal hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 9, 1996, Pages 3180-3190

  Van Wyk, Judson J ^a   Gunther, Daniel F ^a   Ritzén, E Martin ^b   Wedell, Anna ^b   Cutler Jr , Gordon B ^b   Migeon, Claude J ^b   New, Maria I ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTIANDROGEN; AROMATASE INHIBITOR; CORTICOTROPIN; DEXAMETHASONE; ENZYME INHIBITOR; FLUTAMIDE; GLUCOCORTICOID; HORMONE ANTAGONIST; HYDROCORTISONE; KETOCONAZOLE; PREDNISONE; STEROID 21 MONOOXYGENASE; TESTOLACTONE;

ADRENAL GLAND; ADRENALECTOMY; CLINICAL TRIAL; CONGENITAL ADRENAL HYPERPLASIA; DRUG FORMULATION; GENE THERAPY; GONADAL DISEASE; HORMONAL THERAPY; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; NELSON SYNDROME; NOTE; ORAL DRUG ADMINISTRATION; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADRENAL GLANDS; ADRENAL HYPERPLASIA, CONGENITAL; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; HUMANS;

EID: 0029795514     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.9.3180     Document Type: Note

References (13)

1. Wilkins L, Lewis R, Klein R, Rosemberg E. 1950 The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia. Bull Johns Hopkins Hosp. 86:249-252.
2. Helleday J, Siwers B, Ritzen EM, Carlstrom K. 1993 Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab. 76:933-936. |
3. Pescovitz OH, Comite F, Cassorla F, et al. 1984 True precocious puberty complicating congenital adrenal hyperplasia: treatment with luteinizing hormone-releasing analog. J Clin Endocrinol Metab. 58:857-861.
4. Pang S, Kenny F, Foley T, Drash A. 1977 Growth and sexual maturation in treated congenital adrenal hyperplasia. In: Lee P, Plotnick L, Kowarski AA, Migeon C, eds. Congenital adrenal hyperplasia. Baltimore: University Park Press; 233-246.
5. Knorr D, Hinrichsen de Lienau SCG. 1988 Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy. Acta Pediatr Jpn. 30:89-92.
6. Janowski A. 1977 Naturally occurring adrenal steriods with salt losing properties: relationship to congenital adrenal hyperplasia. In: Lee P, Plotnick L, Kowarski AA, Migeon C, eds. Congenital adrenal hyperplasia. Baltimore: University Park Press; 99-112.
7. Duncan M, Duncan R. 1979 An in vitro study of the action of antiglucocorticoids on the thymus weight ratio, antibody litre, and the adrenal-pituitary-hypothalmus axis. J Steroid Biochem. 10:245-259.
8. Keller-Wood ME, Dallman M. 1984 Corticosteroid inhibition of ACTH secretion. Endocr Rev. 5:1-24.
9. Kjaer A. 1993 Vasopressin as a neuroendocrine regulator of anterior pituitary hormone secretion. Acta Endocrinol. 129:489-496.
10. Deleted in proof.
11. Clayton R, Burden AC, Schreiber V, Rosenthal FD. 1977 Secondary pituitary hyperplasia in Addison's disease. Lancet. November. 5:954-956.
12. Zachmann M, Manella B, Kempken B, Knorr-Muerset G, Atares M, Prader A. 1984 Ovarian steroidogenesis in an adrenalectomized girl with 21-hydoxylase dificiency. Clin Endocrinol (Oxf). 21:575-582.
13. von Mühlendahl K, Sippell W. 1989 Adrenalektomie als therapie bei schwer einstellbarem adrenogenitalen syndrom. Monatsschr Kinderheilkunde. 137: 341-344.